Neogen Corporation (NEOG)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Neogen Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Neogen Corporation (NEOG) has returned 32.90% so far this year and 7.15% over the past 12 months. Over the last ten years, NEOG has returned -6.59% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.

Based on dividend-adjusted daily data since Feb 10, 1994, NEOG's average daily return is +0.07%, while the average monthly return is +1.34%. At this rate, your investment would double in approximately 4.3 years.

Historically, 55% of months were positive and 45% were negative. The best month was Jan 2001 with a return of +58.5%, while the worst month was Apr 2025 at -41.8%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 8 months.

On a daily basis, NEOG closed higher 47% of trading days. The best single day was Jan 8, 2026 with a return of +31.6%, while the worst single day was Apr 9, 2025 at -28.7%.

Neogen Corporation has an annualized alpha of 11.73%, beta of 0.68, and R² of 0.08 versus S&P 500 Index. Calculated based on daily prices since February 11, 1994.

• This stock captured 105.46% of S&P 500 Index gains and 104.97% of its losses — amplifying both gains and losses, but participating more in upside than downside.
• Beta of 0.68 may look defensive, but with R² of 0.08 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.08 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

NEOG ranks 45 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.

The table below present risk-adjusted performance metrics for Neogen Corporation (NEOG) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Neogen Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Neogen Corporation was 90.92%, occurring on Apr 17, 2025. The portfolio has not yet recovered.

The current Neogen Corporation drawdown is 80.78%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Neogen Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Neogen Corporation is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.